1 dispersions

International Journal of Pharmaceutics

Volumn 444, Issue 1-2, 2013, Pages 40-46

  Kogermann, K ^a   Penkina, A ^a   Predbannikova, K ^a   Jeeger, K ^a   Veski, P ^a   Rantanen, J ^b   Naelapaa K ^b  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Amorphous solid dispersion; Co milling; Dissolution; Molecular weight of polymer; Polymer; Solubility

Indexed keywords

PIROXICAM; POLYMER; METHYLCELLULOSE; NONSTEROID ANTIINFLAMMATORY AGENT; POVIDONE;

AMORPHOUS SOLID DISPERSION; ARTICLE; CONCENTRATION (PARAMETERS); DISPERSION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; MOLECULAR WEIGHT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAMAN SPECTROMETRY; SOLID STATE; CHEMISTRY; SOLUBILITY; STOMACH JUICE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG STABILITY; GASTRIC JUICE; METHYLCELLULOSE; PIROXICAM; POVIDONE; SOLUBILITY;

EID: 84874296838     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.01.042     Document Type: Article

References (34)

1. H. Al-Obaidi, S. Brocchini, and G. Buckton Anomalous properties of spray dried solid dispersions J. Pharm. Sci. 98 2009 4724 4737
2. D.E. Alonzo, G.G.Z. Zhang, D. Zhou, Y. Gao, and L.S. Taylor Understanding the behavior of amorphous pharmaceutical systems during dissolution Pharm. Res. 27 2010 608 618
3. J. Brouwers, M.E. Brewster, and P. Augustijns Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability J. Pharm. Sci. 98 2009 2549 2572
4. N. Chieng, J. Aaltonen, D. Saville, and T. Rades Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation Eur. J. Pharm. Biopharm. 71 2009 47 54
5. R.J. Chokshi, N.H. Shah, H.K. Sandhu, A.W. Malick, and H. Zia Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration J. Pharm. Sci. 97 2008 2286 2298
6. D.Q.M. Craig The mechanisms of drug release from solid dispersions in water-soluble polymers Int. J. Pharm. 231 2002 131 144
7. D. Engers, J. Teng, J. Jimenez-Novoa, P. Gent, S. Hossack, C. Campbell, J. Thomson, I. Ivanisevic, A. Templeton, S. Byrn, and A. Newman A solid-state approach to enable early development compounds: selection and animal bioavailability studies of an itraconazole amorphous solid dispersion J. Pharm. Sci. 99 2010 3901 3922
8. S. Esnaashari, Y. Javadzadeh, H.K. Batchelor, and B.R. Conway The use of microviscometry to study polymer dissolution from solid dispersion drug delivery systems Int. J. Pharm. 292 2005 227 230
9. A.D. Gift, L.A. Southard, and A.L. Riesberg Influence of polymeric excipient properties on crystal hydrate formation kinetics of caffeine in aqueous slurries J. Pharm. Sci. 101 2012 1755 1762
10. P. Gupta, V.K. Kakumanu, and A.K. Bansal Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective Pharm. Res. 21 2004 1762 1769
11. H.K. Han, B.J. Lee, and H.K. Lee Enhanced dissolution and bioavailability of biochanin A via the preparation of solid dispersion: in vitro and in vivo evaluation Int. J. Pharm. 415 2011 89 94
12. A. Ito, T. Watanabe, S. Yada, T. Hamaura, H. Nakagami, K. Higashi, K. Moribe, and K. Yamamoto Prediction of recrystallization behavior of troglitazone/polyvinylpyrrolidone solid dispersion by solid-state NMR Int. J. Pharm. 383 2010 18 23
13. K. Kogermann, P. Veski, J. Rantanen, and K. Naelapää X-ray powder diffractometry in combination with principal component analysis-a tool for monitoring solid state changes Eur. J. Pharm. Sci. 43 2011 278 289
14. K. Löbmann, R. Laitinen, H. Grohganz, K.C. Gordon, C. Strachan, and T. Rades Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen Mol. Pharm. 8 2011 1919 1928
15. K. Löbmann, C. Strachan, H. Grohganz, T. Rades, O. Korhonen, and R. Laitinen Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactions Eur. J. Pharm. Biopharm. 81 2012 159 169
16. P.J. Marsac, A.C.F. Rumondor, D.E. Nivens, U.S. Kestur, L. Stanciu, and L.S. Taylor Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone) J. Pharm. Sci. 99 2010 169 185
17. B.A. Miller-Chou, and J.L. Koenig A review of polymer dissolution Prog. Polym. Sci. 28 2003 1223 1270
18. Miranda, J.; Sablotsky, S.; 1995. Solubility parameter based drug delivery system and method for altering drug saturation concentration U.S. Patent. Noven Pharmaceuticals Inc.; pp. 1-8.
19. R.I. Moustafine, V.L. Bobyleva, A.V. Bukhovets, V.R. Garipova, T.V. Kabanova, V.A. Kemenova, and G. Van Den Mooter Structural transformations during swelling of polycomplex matrices based on countercharged (meth)acrylate copolymers (Eudragit® EPO/Eudragit® L 100-55) J. Pharm. Sci. 100 2011 874 885
20. P. Mura, N. Zerrouk, N. Mennini, F. Maestrelli, and C. Chemtob Development and characterization of naproxen-chitosan solid systems with improved drug dissolution properties Eur. J. Pharm. Sci. 19 2003 67 75
21. K. Naelapää, J.P. Boetker, P. Veski, J. Rantanen, T. Rades, and K. Kogermann Polymorphic form of piroxicam influences the performance of amorphous material prepared by ball-milling Int. J. Pharm. 429 2012 69 77
22. A. Newman, G. Knipp, and G. Zografi Assessing the performance of amorphous solid dispersions J. Pharm. Sci. 101 2012 1355 1377
23. D. Pahovnik, S. Reven, J. Grdadolnik, R. Borśtnar, J. Mavri, and E. Źagar Determination of the interaction between glimepiride and hyperbranched polymers in solid dispersions J. Pharm. Sci. 100 2011 4700 4709
24. J. Pajander, S. Baldursdottir, J. Rantanen, and J. Østergaard Behaviour of HPMC compacts investigated using UV-imaging Int. J. Pharm. 427 2012 345 353
25. J.E. Patterson, M.B. James, A.H. Forster, R.W. Lancaster, J.M. Butler, and T. Rades The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds J. Pharm. Sci. 94 2005 1998 2012
26. V. Puri, A.K. Dantuluri, and A.K. Bansal Investigation of atypical dissolution behavior of an encapsulated amorphous solid dispersion J. Pharm. Sci. 100 2011 2460 2468
27. M. Savolainen, K. Kogermann, A. Heinz, J. Aaltonen, L. Peltonen, C. Strachan, and J. Yliruusi Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy Eur. J. Pharm. Biopharm. 71 2009 71 79
28. A.T.M. Serajuddin Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs J. Pharm. Sci. 88 1999 1058 1066
29. Y. Shibata, M. Fujii, M. Kokudai, S. Noda, H. Okada, M. Kondoh, and Y. Watanabe Effect of characteristics of compounds on maintenance of an amorphous state in solid dispersion with crospovidone J. Pharm. Sci. 96 2006 1537 1547
30. K. Six, G. Verreck, J. Peeters, M. Brewster, and G. Van den Mooter Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow-dissolving polymers J. Pharm. Sci. 93 2004 124 131
31. V. Tantishaiyakul, N. Kaewnopparat, and S. Ingkatawornwong Properties of solid dispersions of piroxicam in polyvinylpyrrolidone Int. J. Pharm. 181 1999 143 151
32. M. Vialpando, A. Aerts, J. Persoons, J. Marten, and G. Van Den Mooter Evaluation of ordered mesoporous silica as a carrier for poorly soluble drugs: Influence of pressure on the structure and drug release J. Pharm. Sci. 100 2011 3411 3420
33. S.R. Vippagunta, Z. Wang, S. Hornung, and S.L. Krill Factors affecting the formation of eutectic solid dispersions and their dissolution behavior J. Pharm. Sci. 96 2007 294 304
34. J.X. Wu, M. Yang, F. van den Berg, J. Pajander, T. Rades, and J. Rantanen Influence of solvent evaporation rate and formulation factors on solid dispersion physical stability Eur. J. Pharm. Sci. 44 2011 610 620